rxstat › Shortages › Bromfenac
Bromfenac shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Bromfenac products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 26, 2027.
In shortage since
Jul 8, 2025
Est. full return
Mar 26, 2027
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-BROMFENAC
0.07% · SOLUTION · APOTEX INC
DIN 02537788 · since Jul 8, 2025, est. end Mar 26, 2027 · Disruption of the manufacture of the drug.
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jan 5, 2026 · Demand increase for the drug.
ResolvedAPO-BROMFENAC
0.07% · SOLUTION · APOTEX INC
DIN 02537788 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
ResolvedAPO-BROMFENAC
0.07% · SOLUTION · APOTEX INC
DIN 02537788 · ended Jan 4, 2024 · Disruption of the manufacture of the drug.
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jan 11, 2023 · Shortage of an active ingredient.
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Oct 27, 2022 · Shortage of an inactive ingredient or component.
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jul 15, 2022 · Delay in shipping of the drug.
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Nov 5, 2018 · Other (Please describe in comments)
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Aug 21, 2018 · Other (Please describe in comments)
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jun 15, 2018 · Other (Please describe in comments)
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Mar 1, 2017 · Other (Please describe in comments)
ResolvedPROLENSA
0.07% · SOLUTION · BAUSCH & LOMB INC
DIN 02439123 · ended Jun 9, 2017 · Other (Please describe in comments)
What's happening
Bromfenac is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Bromfenac is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).
Recent changes
Common questions
When will Bromfenac be back in stock in Canada?
The latest manufacturer estimate is Mar 26, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Bromfenac in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All antiinflammatory agents shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.